Patents by Inventor P. Boatman

P. Boatman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
    Publication number: 20070254903
    Abstract: The invention provides compounds of Formula (I): and pharmaceutically acceptable salts, solvates and stereoisomers thereof, wherein A, B, E, G, W, X, Y, Z, o, and R1 are as disclosed herein (“Compound(s) of the Invention”), which are useful as cardio-protective and/or neuro-protective agents. The invention also provides pharmaceutical compositions comprising a Compound of the Invention and methods for treating, preventing and/or managing a vascular, cardiovascular or neurological disease or disorder, comprising administering to a patient in need thereof a Compound of the Invention.
    Type: Application
    Filed: December 22, 2004
    Publication date: November 1, 2007
    Applicant: ARENA PHARMACEUTICALS, INC.
    Inventors: P. Boatman, John Adams, Jeanne Moody, Eric Babych, Thomas Schrader
  • Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
    Publication number: 20070073062
    Abstract: The present invention relates to certain fused pyrazole derivatives of Formula (Ia), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like.
    Type: Application
    Filed: November 17, 2006
    Publication date: March 29, 2007
    Inventors: P. Boatman, Thomas Schrader, Graeme Semple, Philip Skinner, Jae-Kyu Jung
  • Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
    Publication number: 20060205955
    Abstract: The present invention relates to certain fused pyrazole derivatives of Formula (Ia), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like.
    Type: Application
    Filed: December 22, 2005
    Publication date: September 14, 2006
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: P. Boatman, Thomas Schrader, Graeme Semple, Philip Skinner, Jae-Kyu Jung